Clinical Trial Update: Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating dapagliflozin for vascular health in patients with type 2 diabetes and endothelial dysfunction was terminated; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Boston University | Conditions: Diabetes Mellitus, Type 2, Endothelial Dysfunction | Phase 4 | Status: TERMINATED | Results posted: 2026-02-11